These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11117989)

  • 1. Pravastatin therapy and the risk of stroke.
    Meilof JF; Uitdehaag BM
    N Engl J Med; 2000 Dec; 343(25):1895; author reply 1895-6. PubMed ID: 11117989
    [No Abstract]   [Full Text] [Related]  

  • 2. Pravastatin therapy and the risk of stroke.
    Fruchter O
    N Engl J Med; 2000 Dec; 343(25):1895; author reply 1895-6. PubMed ID: 11117990
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study].
    Uguccioni M
    Ital Heart J Suppl; 2001 Mar; 2(3):316-7. PubMed ID: 11307791
    [No Abstract]   [Full Text] [Related]  

  • 4. Pravastatin therapy and the risk of stroke.
    Brett AS
    N Engl J Med; 2000 Dec; 343(25):1894-5; author reply 1895-6. PubMed ID: 11117988
    [No Abstract]   [Full Text] [Related]  

  • 5. Pravastatin shown to reduce stroke risk after heart attacks.
    Harv Heart Lett; 1999 May; 9(9):7. PubMed ID: 10198446
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stroke, cholesterol and statins--are there new data about stroke prevention?].
    Ferbert A
    Dtsch Med Wochenschr; 2001 Jun; 126(22):664-70. PubMed ID: 11450627
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study.
    Tonkin AM; Colquhoun D; Emberson J; Hague W; Keech A; Lane G; MacMahon S; Shaw J; Simes RJ; Thompson PL; White HD; Hunt D
    Lancet; 2000 Dec; 356(9245):1871-5. PubMed ID: 11130382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CSE inhibitors after coronary event. How soon administered?].
    MMW Fortschr Med; 2001 May; 143(22):52. PubMed ID: 11460407
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial.
    Thompson PL; Meredith I; Amerena J; Campbell TJ; Sloman JG; Harris PJ;
    Am Heart J; 2004 Jul; 148(1):e2. PubMed ID: 15215811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How low should your cholesterol go? Even lower may be better. For those at highest risk, very low cholesterol levels may help prevent a second heart attack or stroke.
    Health News; 2004 Oct; 10(10):6. PubMed ID: 15584114
    [No Abstract]   [Full Text] [Related]  

  • 12. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
    West MJ; Nestel PJ; Kirby AC; Schnabel R; Sullivan D; Simes RJ; Pollicino C; Lubos E; Münzel TF; White HD; Tonkin AM; Bickel C; Tiret L; Blankenberg S;
    Eur Heart J; 2008 Apr; 29(7):923-31. PubMed ID: 18296678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fewer myocardial infarcts. Statin therapy is even effective in the elderly].
    MMW Fortschr Med; 2003 Mar; 145(11):58. PubMed ID: 12688200
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of pravastatin on coronary events after myocardial infarction.
    Auerbach I; Behar S; Motro M
    N Engl J Med; 1997 Mar; 336(13):962. PubMed ID: 9072702
    [No Abstract]   [Full Text] [Related]  

  • 15. Rosuvastatin for cardiovascular prevention: too many uncertainties.
    Prescrire Int; 2009 Aug; 18(102):176. PubMed ID: 19746571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
    Hennekens CH; Sacks FM; Tonkin A; Jukema JW; Byington RP; Pitt B; Berry DA; Berry SM; Ford NF; Walker AJ; Natarajan K; Sheng-Lin C; Fiedorek FT; Belder R
    Arch Intern Med; 2004 Jan; 164(1):40-4. PubMed ID: 14718320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost effectiveness of pravastatin in secondary coronary prevention in patients with myocardial infarct or unstable angina in Germany. An analysis on the basis of the LIPID trial].
    Szucs TD; Berger K; März W; Schäfer JR
    Herz; 2000 Aug; 25(5):487-94. PubMed ID: 10992997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lowering cholesterol in the elderly--yes, no, or maybe?].
    Gogol M
    MMW Fortschr Med; 2006 Mar; 148(12):40-3. PubMed ID: 16626005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pravastatin and coronary heart disease.
    Bloom JM
    Lancet; 2001 Mar; 357(9261):1040. PubMed ID: 11293615
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.
    Tonkin AM; Eckermann S; White H; Friedlander D; Glasziou P; Magnus P; Kirby A; Mulray S; Denton M; Sallaberger M; Hunt D; Simes J;
    Am Heart J; 2006 Jun; 151(6):1305-12. PubMed ID: 16781242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.